Skip to main content

Syndicate contentEntertainment

Last-resort lower-body amputation effective in extreme cases of bone infection, 25-year review shows

DALLAS -- Nov. 17, 2009 -- A landmark, 25-year review of cases in which surgeons had to remove the lower portion of the body from the waist down for severe pelvic bone infections shows the therapy can add years and quality of life to survivors, say researchers at UT Southwestern Medical Center.

New study ushers in spring-time for slow inactivation

The December 2009 issue of the Journal of General Physiology (JGP) contains a paper by Christopher Ahern (The University of British Columbia, Vancouver) and colleagues that explores pore mutation effects in Shaker and other K+ channels using in vivo nonsense suppression technology.

Stronger graduated driver's licensing program would save lives, prevent injuries in Midwest

A new study shows that three-stage graduated driver's licensing (GDL) policies save lives and prevents injuries throughout the Midwest. The research published in the Wisconsin Medical Journal (Vol. 108, No. 8) also shows how states could save more teen lives and avoid thousands of teen motor vehicle injuries by modifying their GDL policies to include new, proven components.

LA Biomed study finds medication improves health of patients with pulmonary arterial hypertension

In one of the few studies of the long-term effects of medication in the treatment of pulmonary arterial hypertension (PAH) disease, a team of researchers found the health and exercise capacity of PAH patients improved after two years of treatment with ambrisentan, according to a study published in the current edition of the Journal of the American College of Cardiology.

Alternative animal feed part of global fisheries crisis fix: UBC study

Finding alternative feed sources for chickens, pigs and other farm animals will significantly reduce pressure on the world's dwindling fisheries while contributing positively to climate change, according to University of British Columbia researchers.

Scientists discover cells that control inflammation in chronic disease

A new type of immune cell that can be out of control in certain chronic inflammatory diseases, worsening the symptoms of conditions like psoriasis and asthma, is described for the first time this week in the Journal of Clinical Investigation.

Counterfeit euros are detected with an optical mouse

The sensor of some optical mice can be used to easily and cheaply detect counterfeit euros, according to a study published by researchers of the University of Lleida (UdL) in the scientific journal Sensors. Almost 80% of counterfeit coins discovered in Europe in 2008 were two-euro coins.

Wistar researchers show targeting 'normal' cells in tumors slows growth

Targeting the normal cells that surround cancer cells within and around a tumor is a strategy that could greatly increase the effectiveness of traditional anti-cancer treatments, say researchers at The Wistar Institute.

Nanoparticles used in common household items caused genetic damage in mice

Titanium dioxide (TiO2) nanoparticles, found in everything from cosmetics to sunscreen to paint to vitamins, caused systemic genetic damage in mice, according to a comprehensive study conducted by researchers at UCLA's Jonsson Comprehensive Cancer Center.

Penn study finds that antioxidant found in vegetables has implications for treating cystic fibrosis

PHILADELPHIA -- Scientists at the University of Pennsylvania School of Medicine discovered that a dietary antioxidant found in such vegetables as broccoli and cauliflower protects cells from damage caused by chemicals generated during the body's inflammatory response to infection and injury.

UT Southwestern scientist begins to unravel what makes pandemic H1N1 tick

DALLAS -- Nov. 16, 2009 -- As the number of deaths related to the pandemic H1N1 virus, commonly known as "swine flu," continues to rise, researchers have been scrambling to decipher its inner workings and explain why the incidence is lower than expected in older adults.

Boehringer Ingelheim announces Phase III data of flibanserin in pre-menopausal women with HSDD

Ridgefield, CT, November 16, 2009 - Data from pivotal Phase III clinical trials demonstrate that flibanserin 100mg increased the number of satisfying sexual events (SSE) and sexual desire (the co-primary endpoints) while decreasing the distress associated with Hypoactive Sexual Desire Disorder (HSDD).

List makers take note: 10 technologies that made news in 2009 and warrant watching in 2010

WASHINGTON, Nov. 16, 2009 -- A first-of-its kind inhalable measles vaccine for developing countries, where the disease remains a scourge. A "nanogenerator" that could recharge iPods and other electronic devices with a shake. And for Fido and Fluffy, a long-awaited once-a-month pill for both ticks and fleas.

Scientists guide immune cells with light and microparticles

New Haven, Conn. -- A team led by Yale University scientists has developed a new approach to studying how immune cells chase down bacteria in our bodies. Their findings are described in the November 15 issue of Nature Methods Advanced Online Publication.

Penguins and sea lions help produce new atlas

NEW YORK (NOVEMBER 16, 2009) -- Recording hundreds of thousands of individual uplinks from satellite transmitters fitted on penguins, albatrosses, sea lions, and other marine animals, the Wildlife Conservation Society (WCS) and BirdLife International have released the first-ever atlas of the Patagonian Sea -- a globally important but poorly understood South American marine ecosyste



About us

Science Blog was started in August 2002. It lives, breathes and eats press releases from research organizations around the globe. Most of what you read here are press releases from the outfits named in the stories themselves. Got a news story you think belongs here? Let's talk. The other half of the equation is blog posts from readers like you. So if you have an interest in science, please register and join others like you in an ongoing, vibrant dialog about what makes the world tick. Meantime, please take a minute to read our Privacy Policy and Site Disclaimer.


Premium Drupal Themes by Adaptivethemes